ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CSRT Consort Medical Plc

1,010.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Consort Medical Plc LSE:CSRT London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,010.00 1,005.00 1,010.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Consort Medical PLC Director Declaration (5517W)

15/11/2017 9:14am

UK Regulatory


Consort Medical (LSE:CSRT)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Consort Medical Charts.

TIDMCSRT

RNS Number : 5517W

Consort Medical PLC

15 November 2017

Registered Number 406711

Consort Medical plc

Director Declaration

In accordance with Rule 9.6.14 of the UK Listing Rules, Consort Medical plc ('the Company') gives notice that Andrew Hosty, a non-executive Director of the Company, has been appointed a non-executive Director of RHI Magnesita N.V. with effect from 27 October 2017.

Enquiries:

Consort Medical plc

   John Ilett, Company Secretary                                               01442 867920 

Consort Medical plc is a leading, global, single source drug and delivery device company (CDMO). We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Our businesses

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectable products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.

We employ more than 2,000 people globally of which 1,400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNEANFSFFDXFEF

(END) Dow Jones Newswires

November 15, 2017 04:14 ET (09:14 GMT)

1 Year Consort Medical Chart

1 Year Consort Medical Chart

1 Month Consort Medical Chart

1 Month Consort Medical Chart

Your Recent History

Delayed Upgrade Clock